<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34412701</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2051-5960</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>19</Day></PubDate></JournalIssue><Title>Acta neuropathologica communications</Title><ISOAbbreviation>Acta Neuropathol Commun</ISOAbbreviation></Journal><ArticleTitle>Microglial transcriptome analysis in the rNLS8 mouse model of TDP-43 proteinopathy reveals discrete expression profiles associated with neurodegenerative progression and recovery.</ArticleTitle><Pagination><StartPage>140</StartPage><MedlinePgn>140</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">140</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40478-021-01239-x</ELocationID><Abstract><AbstractText>The microglial reaction is a hallmark of neurodegenerative conditions, and elements thereof may exert differential effects on disease progression, either worsening or ameliorating severity. In amyotrophic lateral sclerosis (ALS), a syndrome characterized by cytoplasmic aggregation of TDP-43 protein and atrophy of motor neurons in the cortex and spinal cord, the transcriptomic signatures of microglia during disease progression are incompletely understood. Here, we performed longitudinal RNAseq analysis of cortical and spinal cord microglia from rNLS8 mice, in which doxycycline-regulatable expression of human TDP-43 (hTDP-43) in the cytoplasm of neurons recapitulates many features of ALS. Transgene suppression in rNLS8 mice leads to functional, anatomical and electrophysiological resolution that is dependent on a microglial reaction that is concurrent with recovery rather than disease onset. We identified basal differences between the gene expression profiles of microglia dependent on localization in spinal cord or cortex. Microglia subjected to chronic hTDP-43 overexpression demonstrated transcriptomic changes in both locations. We noted strong upregulation of Apoe, Axl, Cd63, Clec7a, Csf1, Cst7, Igf1, Itgax, Lgals3, Lilrb4, Lpl and Spp1 during late disease and recovery. Importantly, we identified a distinct suite of differentially expressed genes associated with each phase of disease progression and recovery. Differentially expressed genes were associated with chemotaxis, phagocytosis, inflammation, and production of neuroprotective factors. These data provide new insights into the microglial reaction in TDP-43 proteinopathy. Genes differentially expressed during progression and recovery may provide insight into a unique instance in which the microglial reaction promotes functional recovery after neuronal insult.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hunter</LastName><ForeName>Mandana</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4803-7278</Identifier><AffiliationInfo><Affiliation>Center for Neurodegenerative Disease Research (CNDR), Institute on Aging, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104-2676, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spiller</LastName><ForeName>Krista J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Disease Research (CNDR), Institute on Aging, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104-2676, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Spring House, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dominique</LastName><ForeName>Myrna A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Disease Research (CNDR), Institute on Aging, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104-2676, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Disease Research (CNDR), Institute on Aging, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104-2676, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hunter</LastName><ForeName>Francis W</ForeName><Initials>FW</Initials><AffiliationInfo><Affiliation>School of Medical Sciences, University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Spring House, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Terry C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Biogen, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canter</LastName><ForeName>Rebecca G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Biogen, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dementia Discovery Fund, SV Health Managers LLP, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Biogen, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genomics Institute of the Novartis Research Foundation, San Deigo, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ransohoff</LastName><ForeName>Richard M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Third Rock Ventures, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trojanowski</LastName><ForeName>John Q</ForeName><Initials>JQ</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Disease Research (CNDR), Institute on Aging, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104-2676, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Virginia M-Y</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Disease Research (CNDR), Institute on Aging, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104-2676, USA. vmylee@upenn.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AG017586</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS110688</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01NS110688</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG17586</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Neuropathol Commun</MedlineTA><NlmUniqueID>101610673</NlmUniqueID><ISSNLinking>2051-5960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002633" MajorTopicYN="N">Chemotaxis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090862" MajorTopicYN="N">Neuroinflammatory Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000066829" MajorTopicYN="N">Neuroprotection</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010587" MajorTopicYN="N">Phagocytosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000081246" MajorTopicYN="N">RNA-Seq</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057177" MajorTopicYN="N">TDP-43 Proteinopathies</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Microglia</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword><Keyword MajorTopicYN="N">Neuroinflammation</Keyword><Keyword MajorTopicYN="N">Phagocytosis</Keyword><Keyword MajorTopicYN="N">Proteinopathy</Keyword><Keyword MajorTopicYN="N">Recovery</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">rNLS8</Keyword></KeywordList><CoiStatement>KJS and FWH are employees of Janssen Research &amp; Development. TCF is an employee of Biogen. RGC is an employee of SV Health Investors. CJR is an employee of The Genomics Institute of the Novartis Research Foundation. RNR, TCF, RGC and CJR were employees at Biogen at the time this study was performed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>20</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34412701</ArticleId><ArticleId IdType="pmc">PMC8377972</ArticleId><ArticleId IdType="doi">10.1186/s40478-021-01239-x</ArticleId><ArticleId IdType="pii">10.1186/s40478-021-01239-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bianchin MM, Capella HM, Chaves DL, Steindel M, Grisard EC, Ganev GG, et al. Nasu-Hakola Disease (Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy&#x2014;PLOSL): A dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects. Cell Mol Neurobiol. 2004;24:1&#x2013;24. doi: 10.1023/B:CEMN.0000012721.08168.ee.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:CEMN.0000012721.08168.ee</ArticleId><ArticleId IdType="pubmed">15049507</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanden Broeck L, Callaerts P, Dermaut B. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis? Trends Mol Med. 2014;20:66&#x2013;71. doi: 10.1016/j.molmed.2013.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2013.11.003</ArticleId><ArticleId IdType="pubmed">24355761</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W, Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci. 2013;14:248&#x2013;264. doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T, Rothstein JD. Glial cells in amyotrophic lateral sclerosis. Exp Neurol. 2014;262:111&#x2013;120. doi: 10.1016/j.expneurol.2014.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.05.015</ArticleId><ArticleId IdType="pmc">PMC4241182</ArticleId><ArticleId IdType="pubmed">24859452</ArticleId></ArticleIdList></Reference><Reference><Citation>Haukedal H, Freude K. Implications of microglia in amyotrophic lateral sclerosis and frontotemporal dementia. J Mol Biol. 2019;431:1818&#x2013;1829. doi: 10.1016/j.jmb.2019.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2019.02.004</ArticleId><ArticleId IdType="pubmed">30763568</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS, Beers DR, Zhao W, Appel SH. Microglia in ALS: the good, the bad, and the resting. J Neuroimmune Pharmacol. 2009;4:389&#x2013;398. doi: 10.1007/s11481-009-9171-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-009-9171-5</ArticleId><ArticleId IdType="pubmed">19731042</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AK, Spiller KJ, Ge G, Zheng A, Xu Y, Zhou M, et al. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol. 2015;130:643&#x2013;660. doi: 10.1007/s00401-015-1460-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1460-x</ArticleId><ArticleId IdType="pmc">PMC5127391</ArticleId><ArticleId IdType="pubmed">26197969</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller KJ, Restrepo CR, Khan T, Stieber AM, Kwong LK, Trojanowski JQ, et al. Progression of motor neuron disease is accelerated and the ability to recover is compromised with advanced age in rNLS8 mice. Acta Neuropathol Commun. 2016;4:1&#x2013;11. doi: 10.1186/s40478-016-0377-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0377-5</ArticleId><ArticleId IdType="pmc">PMC5043606</ArticleId><ArticleId IdType="pubmed">27687289</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan A, Spiller KJ, Towne C, Kanning KC, Choe GT, Geber A, et al. Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration. Neuron. 2014;81:333&#x2013;348. doi: 10.1016/j.neuron.2013.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.009</ArticleId><ArticleId IdType="pmc">PMC6015650</ArticleId><ArticleId IdType="pubmed">24462097</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller KJ, Khan T, Dominique MA, Restrepo CR, Cotton-Samuel D, Levitan M, et al. Reduction of matrix metalloproteinase 9 (MMP-9) protects motor neurons from TDP-43-triggered death in rNLS8 mice. Neurobiol Dis. 2019;124:133&#x2013;140. doi: 10.1016/j.nbd.2018.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.11.013</ArticleId><ArticleId IdType="pmc">PMC7053168</ArticleId><ArticleId IdType="pubmed">30458231</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller KJ, Cheung CJ, Restrepo CR, Kwong LK, Stieber AM, Trojanowski JQ, et al. Selective motor neuron resistance and recovery in a new inducible mouse model of TDP-43 proteinopathy. J Neurosci. 2016;36:7707&#x2013;7717. doi: 10.1523/JNEUROSCI.1457-16.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1457-16.2016</ArticleId><ArticleId IdType="pmc">PMC6705561</ArticleId><ArticleId IdType="pubmed">27445147</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci. 2000;20:2534&#x2013;2542. doi: 10.1523/JNEUROSCI.20-07-02534.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-07-02534.2000</ArticleId><ArticleId IdType="pmc">PMC6772256</ArticleId><ArticleId IdType="pubmed">10729333</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller KJ, Restrepo CR, Khan T, Dominique MA, Fang TC, Canter RG, et al. Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat Neurosci. 2018;21:329&#x2013;340. doi: 10.1038/s41593-018-0083-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0083-7</ArticleId><ArticleId IdType="pmc">PMC5857237</ArticleId><ArticleId IdType="pubmed">29463850</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes AE, Ferraiuolo L, Haidet-Phillips AM, Schmelzer L, Braun L, Miranda CJ, et al. Microglia induce motor neuron death via the classical NF-&#x3ba;B pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15&#x2013;21. doi: 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Dewey CN (2011) RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3163565</ArticleId><ArticleId IdType="pubmed">21816040</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47. doi: 10.1093/nar/gkv007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv007</ArticleId><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607&#x2013;D613. doi: 10.1093/nar/gky1131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1131</ArticleId><ArticleId IdType="pmc">PMC6323986</ArticleId><ArticleId IdType="pubmed">30476243</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi H, Muruganujan A, Ebert D, Huang X, Thomas PD. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 2019;47:D419&#x2013;D426. doi: 10.1093/nar/gky1038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1038</ArticleId><ArticleId IdType="pmc">PMC6323939</ArticleId><ArticleId IdType="pubmed">30407594</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjaly ZR, Scott KM, Abhinav K, Wijesekera L, Ganesalingam J, Goldstein LH, et al. The sex ratio in amyotrophic lateral sclerosis: a population based study. Amyotroph Lateral Scler. 2010;11:439&#x2013;442. doi: 10.3109/17482961003610853.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482961003610853</ArticleId><ArticleId IdType="pmc">PMC6485484</ArticleId><ArticleId IdType="pubmed">20225930</ArticleId></ArticleIdList></Reference><Reference><Citation>Villa A, Gelosa P, Castiglioni L, Cimino M, Rizzi N, Pepe G, et al. Sex-specific features of microglia from adult mice. Cell Rep. 2018;23:3501&#x2013;3511. doi: 10.1016/j.celrep.2018.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.05.048</ArticleId><ArticleId IdType="pmc">PMC6024879</ArticleId><ArticleId IdType="pubmed">29924994</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of Alzheimer&#x2019;s Disease. Cell. 2017;169:1276&#x2013;1290. doi: 10.1016/j.cell.2017.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.05.018</ArticleId><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Deczkowska A, Keren-Shaul H, Weiner A, Colonna M, Schwartz M, Amit I. Disease-associated microglia: a universal immune sensor of neurodegeneration. Cell. 2018;173:1073&#x2013;1081. doi: 10.1016/j.cell.2018.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.05.003</ArticleId><ArticleId IdType="pubmed">29775591</ArticleId></ArticleIdList></Reference><Reference><Citation>Labandeira-Garcia JL, Costa-Besada MA, Labandeira CM, Villar-Cheda B, Rodr&#xed;guez-Perez AI. Insulin-like growth factor-1 and neuroinflammation. Front Aging Neurosci. 2017;9:365. doi: 10.3389/fnagi.2017.00365.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00365</ArticleId><ArticleId IdType="pmc">PMC5675852</ArticleId><ArticleId IdType="pubmed">29163145</ArticleId></ArticleIdList></Reference><Reference><Citation>Fourgeaud L, Trav&#xe9;s PG, Tufail Y, Leal-Bailey H, Lew ED, Burrola PG, et al. TAM receptors regulate multiple features of microglial physiology. Nature. 2016;532:240&#x2013;244. doi: 10.1038/nature17630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature17630</ArticleId><ArticleId IdType="pmc">PMC5358512</ArticleId><ArticleId IdType="pubmed">27049947</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabert K, Michoel T, Karavolos MH, Clohisey S, Baillie JK, Stevens MP, et al. Microglial brain region-dependent diversity and selective regional sensitivities to aging. Nat Neurosci. 2016;19:504&#x2013;516. doi: 10.1038/nn.4222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4222</ArticleId><ArticleId IdType="pmc">PMC4768346</ArticleId><ArticleId IdType="pubmed">26780511</ArticleId></ArticleIdList></Reference><Reference><Citation>De Biase LM, Schuebel KE, Fusfeld ZH, Jair K, Hawes IA, Cimbro R, et al. Local cues establish and maintain region-specific phenotypes of basal ganglia microglia. Neuron. 2017;95:341&#x2013;356.e6. doi: 10.1016/j.neuron.2017.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.06.020</ArticleId><ArticleId IdType="pmc">PMC5754189</ArticleId><ArticleId IdType="pubmed">28689984</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay TL, Mai D, Dautzenberg J, Fern&#xe1;ndez-Klett F, Lin G, Sagar, et al. A new fate mapping system reveals context-dependent random or clonal expansion of microglia. Nat Neurosci. 2017;20:793&#x2013;803. doi: 10.1038/nn.4547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4547</ArticleId><ArticleId IdType="pubmed">28414331</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xfc;rcher NR, Loggia ML, Lawson R, Chonde DB, Izquierdo-Garcia D, Yasek JE, et al. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [11C]-PBR28. NeuroImage Clin. 2015;7:409&#x2013;414. doi: 10.1016/j.nicl.2015.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2015.01.009</ArticleId><ArticleId IdType="pmc">PMC4310932</ArticleId><ArticleId IdType="pubmed">25685708</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Tauber C, Vercoullie J, Arlicot N, Prunier C, Praline J, et al. Molecular imaging of microglial activation in amyotrophic lateral sclerosis. PLoS One. 2013;7:e52941. doi: 10.1371/journal.pone.0052941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052941</ArticleId><ArticleId IdType="pmc">PMC3534121</ArticleId><ArticleId IdType="pubmed">23300829</ArticleId></ArticleIdList></Reference><Reference><Citation>Holtman IR, Raj DD, Miller JA, Schaafsma W, Yin Z, Brouwer N, et al. Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis. Acta Neuropathol Commun. 2015;3:31. doi: 10.1186/s40478-015-0203-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0203-5</ArticleId><ArticleId IdType="pmc">PMC4489356</ArticleId><ArticleId IdType="pubmed">26001565</ArticleId></ArticleIdList></Reference><Reference><Citation>Linger RMA, Keating AK, Earp HS, Graham DK. Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors. Expert Opin Ther Targets. 2010;14:1073&#x2013;1090. doi: 10.1517/14728222.2010.515980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14728222.2010.515980</ArticleId><ArticleId IdType="pmc">PMC3342018</ArticleId><ArticleId IdType="pubmed">20809868</ArticleId></ArticleIdList></Reference><Reference><Citation>Frenkel D, Wilkinson K, Zhao L, Hickman SE, Means TK, Puckett L, et al. Scara1 deficiency impairs clearance of soluble amyloid-&#x3b2; by mononuclear phagocytes and accelerates Alzheimer&#x2019;s-like disease progression. Nat Commun. 2013;4:2030. doi: 10.1038/ncomms3030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms3030</ArticleId><ArticleId IdType="pmc">PMC3702268</ArticleId><ArticleId IdType="pubmed">23799536</ArticleId></ArticleIdList></Reference><Reference><Citation>Frenkel D, Puckett L, Petrovic S, Xia W, Chen G, Vega J, et al. A nasal proteosome adjuvant activates microglia and prevents amyloid deposition. Ann Neurol. 2008;63:591&#x2013;601. doi: 10.1002/ana.21340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21340</ArticleId><ArticleId IdType="pmc">PMC2747093</ArticleId><ArticleId IdType="pubmed">18360829</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugent AA, Lin K, van Lengerich B, Lianoglou S, Przybyla L, Davis SS, et al. TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge. Neuron. 2020;105:837&#x2013;854.e9. doi: 10.1016/j.neuron.2019.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.12.007</ArticleId><ArticleId IdType="pubmed">31902528</ArticleId></ArticleIdList></Reference><Reference><Citation>Schr&#xf6;der B. The multifaceted roles of the invariant chain CD74 &#x2014; More than just a chaperone. Biochim Biophys Acta - Mol Cell Res. 2016;1863:1269&#x2013;1281. doi: 10.1016/j.bbamcr.2016.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2016.03.026</ArticleId><ArticleId IdType="pubmed">27033518</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoochani A, Schwarz MA, Yakubov E, Engelhorn T, Doerfler A, Buchfelder M, et al. MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis. Oncogene. 2016;35:6246&#x2013;6261. doi: 10.1038/onc.2016.160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2016.160</ArticleId><ArticleId IdType="pubmed">27157615</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu JK, Cho T, Choi HB, Wang YT, McLarnon JG. Microglial VEGF receptor response is an integral chemotactic component in Alzheimer&#x2019;s disease pathology. J Neurosci. 2009;29:3&#x2013;13. doi: 10.1523/JNEUROSCI.2888-08.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2888-08.2009</ArticleId><ArticleId IdType="pmc">PMC6664925</ArticleId><ArticleId IdType="pubmed">19129379</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieto-Est&#xe9;vez V, Defterali &#xc7;, Vicario-Abej&#xf3;n C. IGF-I: A key growth factor that regulates neurogenesis and synaptogenesis from embryonic to adult stages of the brain. Front Neurosci. 2016;10:52. doi: 10.3389/fnins.2016.00052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2016.00052</ArticleId><ArticleId IdType="pmc">PMC4763060</ArticleId><ArticleId IdType="pubmed">26941597</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrigley S, Arafa D, Tropea D. Insulin-like growth factor 1: at the crossroads of brain development and aging. Front Cell Neurosci. 2017;11:14. doi: 10.3389/fncel.2017.00014.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00014</ArticleId><ArticleId IdType="pmc">PMC5285390</ArticleId><ArticleId IdType="pubmed">28203146</ArticleId></ArticleIdList></Reference><Reference><Citation>Arroba AI, &#xc1;lvarez-Lindo N, van Rooijen N, de la Rosa EJ. Microglia-mediated IGF-I neuroprotection in the rd10 mouse model of Retinitis Pigmentosa. Invest Ophthalmol Vis Sci. 2011;52:9124&#x2013;9130. doi: 10.1167/iovs.11-7736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.11-7736</ArticleId><ArticleId IdType="pubmed">22039242</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueno M, Fujita Y, Tanaka T, Nakamura Y, Kikuta J, Ishii M, et al. Layer V cortical neurons require microglial support for survival during postnatal development. Nat Neurosci. 2013;16:543&#x2013;551. doi: 10.1038/nn.3358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3358</ArticleId><ArticleId IdType="pubmed">23525041</ArticleId></ArticleIdList></Reference><Reference><Citation>Grinberg YY, Dibbern ME, Levasseur VA, Kraig RP. Insulin-like growth factor-1 abrogates microglial oxidative stress and TNF-&#x3b1; responses to spreading depression. J Neurochem. 2013;126:662&#x2013;672. doi: 10.1111/jnc.12267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12267</ArticleId><ArticleId IdType="pmc">PMC3752330</ArticleId><ArticleId IdType="pubmed">23586526</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu IM, Chen A, Zheng Y, Kosaras B, Tsiftsoglou SA, Vartanian TK, et al. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc Natl Acad Sci. 2008;105:17913. doi: 10.1073/pnas.0804610105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0804610105</ArticleId><ArticleId IdType="pmc">PMC2581614</ArticleId><ArticleId IdType="pubmed">18997009</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Chen T, Han C, He D, Liu H, An H, et al. Lysosome-associated small Rab GTPase Rab7b negatively regulates TLR4 signaling in macrophages by promoting lysosomal degradation of TLR4. Blood. 2007;110:962&#x2013;971. doi: 10.1182/blood-2007-01-066027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2007-01-066027</ArticleId><ArticleId IdType="pubmed">17395780</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E-J, Kim H-S. The anti-inflammatory role of tissue inhibitor of metalloproteinase-2 in lipopolysaccharide-stimulated microglia. J Neuroinflammation. 2014;11:116. doi: 10.1186/1742-2094-11-116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-116</ArticleId><ArticleId IdType="pmc">PMC4091675</ArticleId><ArticleId IdType="pubmed">24970341</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster R, Kandanearatchi A, Beasley C, Williams B, Khan N, Fagerhol MK, et al. Calprotectin in microglia from frontal cortex is up-regulated in schizophrenia: evidence for an inflammatory process? Eur J Neurosci. 2006;24:3561&#x2013;3566. doi: 10.1111/j.1460-9568.2006.05219.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2006.05219.x</ArticleId><ArticleId IdType="pubmed">17229104</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg-Hansen P, Vandvik B, Fagerhol M, Holm&#xf8;y T. Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis. J Neuroimmunol. 2009;216:98&#x2013;102. doi: 10.1016/j.jneuroim.2009.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2009.09.006</ArticleId><ArticleId IdType="pubmed">19800696</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Klechikov AG, Gharibyan AL, W&#xe4;rml&#xe4;nder SKTS, Jarvet J, Zhao L, et al. The role of pro-inflammatory S100A9 in Alzheimer&#x2019;s disease amyloid-neuroinflammatory cascade. Acta Neuropathol. 2014;127:507&#x2013;522. doi: 10.1007/s00401-013-1208-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1208-4</ArticleId><ArticleId IdType="pmc">PMC4148179</ArticleId><ArticleId IdType="pubmed">24240735</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HJ, Savelieff MG, Kang J, Brophy MB, Nakashige TG, Lee SJC, et al. Calprotectin influences the aggregation of metal-free and metal-bound amyloid-&#x3b2; by direct interaction. Metallomics. 2018;10:1116&#x2013;1127. doi: 10.1039/C8MT00091C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C8MT00091C</ArticleId><ArticleId IdType="pubmed">30046785</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MAD, et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med. 2007;13:1042&#x2013;1049. doi: 10.1038/nm1638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1638</ArticleId><ArticleId IdType="pubmed">17767165</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Q, Li X, Zhou H, Zheng L, Shi J. S100A11 protects against neuronal cell apoptosis induced by cerebral ischemia via inhibiting the nuclear translocation of annexin A1. Cell Death Dis. 2018;9:657. doi: 10.1038/s41419-018-0686-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0686-7</ArticleId><ArticleId IdType="pmc">PMC5974363</ArticleId><ArticleId IdType="pubmed">29844306</ArticleId></ArticleIdList></Reference><Reference><Citation>Ries M, Loiola R, Shah UN, Gentleman SM, Solito E, Sastre M. The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-&#x3b2; peptide. J Neuroinflammation. 2016;13:234. doi: 10.1186/s12974-016-0692-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0692-6</ArticleId><ArticleId IdType="pmc">PMC5010757</ArticleId><ArticleId IdType="pubmed">27590054</ArticleId></ArticleIdList></Reference><Reference><Citation>McArthur S, Cristante E, Paterno M, Christian H, Roncaroli F, Gillies GE, et al. Annexin A1: A central player in the anti-inflammatory and neuroprotective role of microglia. J Immunol. 2010;185:6317&#x2013;6328. doi: 10.4049/jimmunol.1001095.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1001095</ArticleId><ArticleId IdType="pmc">PMC3145124</ArticleId><ArticleId IdType="pubmed">20962261</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang SS, Ren Y, Liu C-C, Kurti A, Baker KE, Bu G, et al. Lipocalin-2 protects the brain during inflammatory conditions. Mol Psychiatry. 2018;23:344&#x2013;350. doi: 10.1038/mp.2016.243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2016.243</ArticleId><ArticleId IdType="pmc">PMC5503822</ArticleId><ArticleId IdType="pubmed">28070126</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Lee J, Kim S, Park J-Y, Lee W-H, Mori K, et al. A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia. J Immunol. 2007;179:3231&#x2013;3241. doi: 10.4049/jimmunol.179.5.3231.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.179.5.3231</ArticleId><ArticleId IdType="pubmed">17709539</ArticleId></ArticleIdList></Reference><Reference><Citation>Garland P, Morton MJ, Haskins W, Zolnourian A, Durnford A, Gaastra B et al (2020) Haemoglobin causes neuronal damage in vivo which is preventable by haptoglobin. Brain Commun 2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7188517</ArticleId><ArticleId IdType="pubmed">32346673</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Xiaokaiti Y, Wang G, Xu X, Chen L, Huang X, et al. Inhibition of PDE2 reverses beta amyloid induced memory impairment through regulation of PKA/PKG-dependent neuro-inflammatory and apoptotic pathways. Sci Rep. 2017;7:12044. doi: 10.1038/s41598-017-08070-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-08070-2</ArticleId><ArticleId IdType="pmc">PMC5608906</ArticleId><ArticleId IdType="pubmed">28935920</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernier L-P, Bohlen CJ, York EM, Choi HB, Kamyabi A, Dissing-Olesen L, et al. Nanoscale surveillance of the brain by microglia via cAMP-regulated filopodia. Cell Rep. 2019;27:2895&#x2013;2908.e4. doi: 10.1016/j.celrep.2019.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.05.010</ArticleId><ArticleId IdType="pubmed">31167136</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ, Bosco D, Leclerc A, Tamrazian E, Vanderburg C, Russ C, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Rogelj B, Hortob&#xe1;gyi T, De Vos KJ, Nishimura AL, Sreedharan J, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>